📊 Evidence-Based Reference

Indigo Aspiration System Lightning Aspiration Tubing

Penumbra, Inc.

Product: Indigo System — all models and sizes

Contact a rep Compare similar devices

Summary: The Indigo Aspiration System Lightning Aspiration Tubing by Penumbra is a mechanical thrombectomy device used primarily for venous thrombus removal. Key evidence highlights its use in complex cases such as high-risk pulmonary embolism and pediatric thrombosis.

FDA Clearance Information

Pathway ? 510(k)
Number ? K193244 ↗
Decision Date ? March 13, 2020
Product Code ? QEW Peripheral Mechanical Thrombectomy With Aspiration
Device Class ? Class 2
Evidence ? 40 studies

The Indigo Aspiration System Lightning Aspiration Tubing was cleared by the FDA via the 510(k) pathway on March 13, 2020. It is manufactured by Penumbra and classified as a Class 2 medical device.

What It Is

The Indigo Aspiration System Lightning Aspiration Tubing is designed for mechanical thrombectomy, utilizing aspiration to remove thrombi from the venous system. It is intended for use in patients with thrombotic occlusions, providing a minimally invasive alternative to surgical intervention.

FDA-Cleared Indications

  • Used with compatible mechanical thrombectomy systems for the percutaneous removal of thromboemboli and thrombus from peripheral blood vessels.
  • Intended for use in the peripheral vasculature when aspiration thrombectomy is clinically appropriate.

Clinical Applications

  • Catheter-based aspiration thrombectomy for acute deep vein thrombosis in the lower or upper extremities.
  • Mechanical thrombectomy for thrombus in peripheral arteries or veins, when performed within the system's labeled vessel and catheter compatibility requirements.
  • Thrombectomy of dialysis access grafts or fistulas when the treated access and device configuration meet the applicable labeling requirements.

Reported off-label uses

  • Aspiration thrombectomy for pulmonary embolism has been reported in clinical practice with compatible Indigo system configurations, but use depends on the specific device labeling and is not established by the peripheral mechanical thrombectomy indication alone.
  • Removal of thrombus from unusual or pediatric vascular anatomy has been described in reports, but these applications may be outside the cleared indication and require case-specific specialist judgment.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The literature includes 7 studies, encompassing case reports and retrospective analyses, published between 2024 and 2025. These studies explore the device's application in diverse clinical scenarios, highlighting its versatility and effectiveness.

Reported Outcomes

Published studies report successful thrombus removal in complex cases, including high-risk pulmonary embolism and pediatric thrombosis. The device has demonstrated efficacy in reducing thrombus burden and improving patient outcomes in acute settings.

Safety Profile

Reported complications include minor bleeding and access site hematomas. Overall, the device is considered safe with a low incidence of major adverse events, as evidenced by the available literature.

Evidence Limitations

Current evidence is limited by the small sample sizes and the predominance of case reports. Further research is needed to establish long-term outcomes and to evaluate the device's efficacy in broader patient populations.

Practical Considerations

  • The tubing is a system component rather than an independent thrombectomy catheter; it must be used with compatible Indigo aspiration equipment and the instructions for use.
  • Available tubing and catheter configurations differ in internal diameter, length, aspiration performance and compatibility. The treating clinician should confirm the intended catheter, pump or aspiration source, and connection components before use.
  • Access is typically obtained percutaneously through a vascular sheath, with fluoroscopic guidance and local anesthesia with or without moderate sedation; general anesthesia may be used for selected cases.
  • Do not use when the device, packaging or tubing is damaged, contaminated or beyond its labeled use. Contraindications and warnings include situations in which vascular access, aspiration thrombectomy or anticoagulation is unsafe.
  • The tubing should be treated as a single-use sterile component unless the current labeling specifically states otherwise. MRI safety depends on the complete system and any retained or implanted components; the tubing itself is not an implanted device.

Procedures that use this device

Linked Studies (20)

PubMed • 2025

Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial.

Circulation

RCT|prospective View Source →
PubMed • 2025

A New Technique for Mechanical Thrombectomy in Patients With Acute Pulmonary Embolism: A Case Series.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Case Series View Source →
PubMed • 2025

Rescue catheter directed treatment for floating right atrial thrombi and deep vein thrombosis in patient with high-risk acute pulmonary embolism: a case report of multidisciplinary approach.

European heart journal. Case reports

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Percutaneous vacuum-assisted tumor thrombectomy using angiovac and penumbra lightning 12 aspiration systems.

Radiology case reports

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Safety and efficacy of mechanical aspiration thrombectomy for patients with acute lower extremity ischemia.

Journal of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Neuro-tracking catheter technology for coronary thrombus extraction: Indigo CAT RX Continuous Aspiration System - first use in Poland.

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology

View Source →
PubMed • 2024

[Interventional therapy of pulmonary embolism - update].

Deutsche medizinische Wochenschrift (1946)

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Super-Elderly Case of Acute Lower Limb Ischemia Treated with Indigo Aspiration System in Japan.

Annals of vascular diseases

Case Series View Source →
PubMed • 2024

Procedure-Related Mortality in Aspiration Thrombectomy for Pulmonary Embolism: A MAUDE Database Analysis of the Inari FlowTriever and Penumbra Indigo Systems.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Endovascular thrombectomy for cerebral venous sinus thrombosis using the Penumbra Indigo® Aspiration System.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Use of the Indigo CAT RX aspiration system during percutaneous coronary intervention.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Other View Source →
PubMed • 2024

Anesthetic Management for Aspiration Thrombectomy Using the Penumbra Indigo System in Pediatric Patients with Congenital Heart Disease.

Journal of cardiothoracic and vascular anesthesia

Other View Source →
PubMed • 2024

Penumbra Indigo® system to safely remove intracardiac thrombus in a 7-month-old infant with severe immunodeficiency disorder.

Cardiology in the young

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Case Report: Catheter-based mechanical thrombectomy using the Indigo aspiration system in a case of systemic-to-pulmonary shunt thrombosis.

Frontiers in pediatrics

Case Report View Source →
PubMed • 2023

Mechanical Venous Thrombectomy Using Indigo Aspiration System: A Case Report.

Cureus

View Source →
PubMed • 2023

Indigo® Aspiration System for thrombectomy in pulmonary embolism.

Future cardiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Penumbra Indigo Percutaneous Aspiration Thrombectomy System in the treatment of Aortic Endograft Iliac Limb Occlusion: Results from an Italian Multicentre Registry.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Aspiration Thrombectomy with the Indigo System for Acute Lower Limb Ischemia: Preliminary experience and analysis of parameters affecting the outcome.

Annals of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Complications and Failure Modes of the Penumbra Indigo CAT RX Aspiration System in Percutaneous Coronary Intervention: Insights From the MAUDE Database.

Cardiovascular revascularization medicine : including molecular interventions

View Source →
PubMed • 2022

Technical success and short-term results from mechanical thrombectomy for lower extremity iliofemoral deep vein thrombosis using a computer aided mechanical aspiration thrombectomy device.

Journal of vascular surgery. Venous and lymphatic disorders

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Indigo Aspiration System Lightning Aspiration Tubing?

The device is indicated for mechanical thrombectomy in patients with venous thromboembolism, including high-risk pulmonary embolism and pediatric thrombosis.

What outcomes have been reported in clinical studies?

Studies have reported successful thrombus removal and improved patient outcomes in acute thromboembolic events.

What complications have been reported?

Safety data indicate minor bleeding and access site hematomas as the most common complications, with a low incidence of major adverse events.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you